Gerard J. Marek

NeuroscienceBiochemistry, Genetics and Molecular BiologyMedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder”.

A phase 1b study to investigate the potential interactions between ASP8062 and buprenorphine/naloxone in patients with opioid use disorder

Journal of Psychopharmacology(2023)10.1177/02698811221149657

N/A

0.250DataRank · unranked

4 citations

Mark Walzer, Mary Beth Blauwet, Anna Spence, Nakyo Heo, Debra Kelsh +5 more

Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats

Journal of Pharmacology and Experimental Therapeutics(2020)10.1124/jpet.119.264069

N/A

0DataRank · unranked

10 citations

Allyson A. Salek, Gerard J. Marek